Company Description
SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.
The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products.
It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated design; iFuse TORQ, a line of 3D-printed threaded implants designed for applications in pelvic trauma and sacroliliac fusion; and iFuse Bedrock Granite Implant System that provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion; and iFuse TORQ TNT to treat pelvic trauma and sacroiliac joint dysfunction, as well as iFuse INTRA implants that are marketed as human cells, tissues, and cellular or tissue-based products.
The company markets its products primarily with a direct sales force, as well as through third-party sales agent and resellers.
SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
| Country | United States |
| Founded | 2008 |
| IPO Date | Oct 17, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 349 |
| CEO | Laura Francis |
Contact Details
Address: 471 El Camino Real, Suite 101 Santa Clara, California 95050 United States | |
| Phone | 408 207 0700 |
| Website | si-bone.com |
Stock Details
| Ticker Symbol | SIBN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001459839 |
| CUSIP Number | 825704109 |
| ISIN Number | US8257041090 |
| Employer ID | 26-2216351 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Laura A. Francis MBA | Chief Executive Officer and Director |
| Jeffrey W. Dunn | Executive Chairman |
| Anshul Maheshwari | Chief Financial Officer |
| Anthony J. Recupero | President of Commercial Operations |
| Dr. Scott A. Yerby Ph.D. | Senior Vice President of Engineering and Chief Technology Officer |
| Saqib Iqbal | Director of FP&A and Investor Relations |
| Michael A. Pisetsky J.D. | Chief Business and Legal Affairs Officer, Secretary and General Counsel |
| Nikolas F. Kerr | Senior Vice President of Product, Marketing and Business Development |
| Aimee Einstein | Vice President of People and Culture |
| Dr. Daniel Joseph Cher M.D. | Senior Vice President of Clinical and Regulatory Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 7, 2025 | 144 | Filing |
| Jul 3, 2025 | 144 | Filing |
| Jun 6, 2025 | 8-K | Current Report |
| May 19, 2025 | 144 | Filing |
| May 19, 2025 | 144 | Filing |
| May 16, 2025 | 144 | Filing |
| May 15, 2025 | SCHEDULE 13G/A | Filing |
| May 15, 2025 | SCHEDULE 13G/A | Filing |
| May 12, 2025 | 144 | Filing |
| May 8, 2025 | 144 | Filing |